FADS2 and adrenal cortex carcinoma: We treated NCI-H295R adrenocortical carcinoma cells for 18 hours with the FADS2 inhibitor SC-26196 and analyzed the lipidome of mitochondrial fractions [identified by succinate dehydrogenase B (SDHB) expression] by liquid chromatography–tandem mass spectrometry (LC-MS/MS) (fig.